Immuneering (IMRX) Prepaid Assets (2020 - 2026)
Immuneering (IMRX) recorded quarterly Prepaid Assets of $4.7 million in Q1 2026, up 38.1% quarter-over-quarter from $3.4 million in Q4 2025, and up 101.48% on a YoY basis from $2.3 million in Q1 2025.
Immuneering (IMRX) Prepaid Assets (2020 - 2026) Analysis & Trends
Immuneering's Prepaid Assets history runs 7 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 101.48% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 101.48% YoY), while the FY2025 annual figure was $3.4 million, down 0.82% from the prior year.
- Prepaid Assets was $4.7 million for Q1 2026 at Immuneering, up from $3.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.7 million in Q1 2026 to a low of $890409.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $2.9 million across 5 years, with a median of $3.2 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 183.21% in 2023, then sank 66.56% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $3.2 million in 2022, then grew by 6.49% to $3.4 million in 2023, then rose by 0.73% to $3.4 million in 2024, then decreased by 0.82% to $3.4 million in 2025, then jumped by 38.1% to $4.7 million in 2026.
- The last three Prepaid Assets figures came in at $4.7 million (Q1 2026), $3.4 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.72 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 3.34 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 890,409.00 |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 3.36 Mn |
| Jun 30, 2021 | 696,684.00 |